Penumbra
PEN
#1784
Rank
โ‚ฌ8.81 B
Marketcap
229,57ย โ‚ฌ
Share price
0.54%
Change (1 day)
8.87%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

Penumbra (PEN) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚ฌ0.35 Billion

According to Penumbra's latest financial reports the company's total liabilities are โ‚ฌ0.35 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Penumbra - Total liabilities on balance sheet (from 2014 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚ฌ0.34 B-1.57%
2022-12-31โ‚ฌ0.34 B35.29%
2021-12-31โ‚ฌ0.25 B70.26%
2020-12-31โ‚ฌ0.15 B-6.44%
2019-12-31โ‚ฌ0.16 B98.85%
2018-12-31โ‚ฌ80.93 M27.35%
2017-12-31โ‚ฌ63.55 M60.29%
2016-12-31โ‚ฌ39.65 M38.4%
2015-12-31โ‚ฌ28.65 M-73.95%
2014-12-31โ‚ฌ0.10 B91.74%
2013-12-31โ‚ฌ57.35 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ0.25 B-29.98%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.00 B 181.37%๐Ÿ‡บ๐Ÿ‡ธ USA